
Cefixna-50 Dry Syrup
January 14, 2025
Cefixna-O Dry Syrup
January 14, 2025Cefixna- CV
Cefixime 50mg + Clavulanic Acid 31.25mg Dry Syrup with water
Product Description
Cefixna-CV Dry Syrup is a pediatric antibiotic formulation containing Cefixime 50 mg and Clavulanic Acid 31.25 mg. It is used for the effective treatment of a variety of bacterial infections in children.
Cefixime is a third-generation cephalosporin antibiotic that works by inhibiting bacterial cell wall synthesis, while Clavulanic Acid enhances its effectiveness by preventing bacterial resistance. This combination provides broad-spectrum coverage and improved clinical outcomes.
The dry syrup is reconstituted with water to form an oral suspension, ensuring ease of administration in pediatric patients.
🔹 Key Benefits
- Broad-spectrum antibiotic for pediatric infections
- Effective against resistant bacteria
- Helps provide faster recovery
- Easy-to-administer oral suspension
- Suitable for children as prescribed
🔹 Key Ingredients
- Cefixime – 50 mg (Cephalosporin antibiotic)
- Clavulanic Acid – 31.25 mg (Beta-lactamase inhibitor)
🔹 Indications
- Respiratory tract infections
- Ear infections (otitis media)
- Throat infections (tonsillitis, pharyngitis)
- Urinary tract infections
- Typhoid fever
- Skin and soft tissue infections
🔹 Dosage / Usage
- Use as directed by a pediatrician
- Reconstitute with clean water up to the marked level
- Shake well before each use
- Complete the full prescribed course
🔹 Precautions
- Use under medical supervision only
- Do not skip doses or discontinue early
- Check for cephalosporin or penicillin allergy
- May cause mild gastrointestinal side effects
- Store in a cool and dry place
- Keep out of reach of children
Common side effects may include nausea, diarrhea, abdominal discomfort, headache, and mild skin rash. Rarely, allergic reactions such as itching, swelling, or difficulty breathing may occur.
Cefixna- CV Dry Syrup is indicated for the treatment of bacterial infections, including respiratory tract infections, otitis media, UTIs, and skin and soft tissue infections caused by susceptible bacteria.
Shake well before use. Administer the exact dosage as advised by the physician. Complete the full course of treatment to prevent resistance, even if symptoms improve earlier.
Store the dry powder in a cool, dry place below 25°C. After reconstitution, refrigerate and use within the prescribed time as mentioned on the label.
Product Description
Cefixna-CV Dry Syrup is a pediatric antibiotic formulation containing Cefixime 50 mg and Clavulanic Acid 31.25 mg. It is used for the effective treatment of a variety of bacterial infections in children.
Cefixime is a third-generation cephalosporin antibiotic that works by inhibiting bacterial cell wall synthesis, while Clavulanic Acid enhances its effectiveness by preventing bacterial resistance. This combination provides broad-spectrum coverage and improved clinical outcomes.
The dry syrup is reconstituted with water to form an oral suspension, ensuring ease of administration in pediatric patients.
🔹 Key Benefits
- Broad-spectrum antibiotic for pediatric infections
- Effective against resistant bacteria
- Helps provide faster recovery
- Easy-to-administer oral suspension
- Suitable for children as prescribed
🔹 Key Ingredients
- Cefixime – 50 mg (Cephalosporin antibiotic)
- Clavulanic Acid – 31.25 mg (Beta-lactamase inhibitor)
🔹 Indications
- Respiratory tract infections
- Ear infections (otitis media)
- Throat infections (tonsillitis, pharyngitis)
- Urinary tract infections
- Typhoid fever
- Skin and soft tissue infections
🔹 Dosage / Usage
- Use as directed by a pediatrician
- Reconstitute with clean water up to the marked level
- Shake well before each use
- Complete the full prescribed course
🔹 Precautions
- Use under medical supervision only
- Do not skip doses or discontinue early
- Check for cephalosporin or penicillin allergy
- May cause mild gastrointestinal side effects
- Store in a cool and dry place
- Keep out of reach of children
| Packing |
|---|





